Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis

AIM: To assess the relative efficacy of disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) including newer therapies (ozanimod, ponesimod, ublituximab) using network meta-analysis (NMA). MATERIALS & METHODS: Bayesian NMAs for annualised relapse rate (ARR) and time to 3-mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Samjoo, Imtiaz A, Drudge, Christopher, Walsh, Sarah, Tiwari, Santosh, Brennan, Róisín, Boer, Ibolya, Häring, Dieter A, Klotz, Luisa, Adlard, Nicholas, Banhazi, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508312/
https://www.ncbi.nlm.nih.gov/pubmed/37265062
http://dx.doi.org/10.57264/cer-2023-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508312/
https://www.ncbi.nlm.nih.gov/pubmed/37265062
http://dx.doi.org/10.57264/cer-2023-0016

Ejemplares similares